Compound information
- Natural Products
- ZC869580
- Molecular Formula
- C20H27N3O4S
- Molecular Weight
- 405.172227344 g/mol
- Structure
-
- IUPAC Name
- N-[4-[4-[(1S,6S)-norcarane-7-carbonyl]piperazin-1-yl]sulfonylphenyl]acetamide
- InChI
- InChI=1S/C20H27N3O4S/c1-14(24)21-15-6-8-16(9-7-15)28(26,27)23-12-10-22(11-13-23)20(25)19-17-4-2-3-5-18(17)19/h6-9,17-19H,2-5,10-13H2,1H3,(H,21,24)/t17-,18-/m0/s1
- InChI Key
- GRMWLVUBEDYPPQ-ROUUACIJSA-N
- SMILES
- CC(=O)Nc1ccc(S(=O)(=O)N2CCN(C(=O)C3[C@H]4CCCC[C@H]34)CC2)cc1
- Source
- ZINC000100773173
Warheads
- Cyclopropane
-
ADMET Property
Physicochemical Property
Property | Value | Property | Value |
---|---|---|---|
Heavy Atom Count | 28 | Ring Count | 4 |
Heteroatom Count | 8 | Rotatable Bond Count | 4 |
Hydrogen Bond Acceptor Count | 4 | Hydrogen Bond Donor Count | 1 |
Topological Polar Surface Area | 86.79 Å2 | LogP | 1.929 |
LogS | -3.33 | LogD | 1.911 |
Absorption
Property | Value | Property | Value |
---|---|---|---|
Pgp inhibitor | 0.009 | Pgp substrate | 0.756 |
HIA | 0.966 | F20 % | 0.993 |
F30 % | 0.812 | Caco-2 | -4.972 |
MDCK | -5.532 |
Distribution
Property | Value | Property | Value |
---|---|---|---|
BBB Penetration | 0.157 | PPB | 98.069 |
VD | 0.687 | Fu | 1.049 |
Metabolism
Property | Value | Property | Value |
---|---|---|---|
CYP1A2 inhibitor | 0.0 | CYP1A2 substrate | 0.613 |
CYP2A6 substrate | 0.575 | CYP2B6 substrate | 0.562 |
CYP2C19 inhibitor | 0.317 | CYP2C19 substrate | 0.976 |
CYP2C8 substrate | 0.668 | CYP2C9 inhibitor | 0.17 |
CYP2C9 substrate | 1.0 | CYP2D6 inhibitor | 0.007 |
CYP2D6 substrate | 0.962 | CYP2E1 substrate | 0.906 |
CYP3A4 inhibitor | 0.033 | CYP3A4 substrate | 1.0 |
Excretion
Property | Value | Property | Value |
---|---|---|---|
T1/2 | 0.367 | CL | 5.106 |
Toxicity
Property | Value | Property | Value |
---|---|---|---|
hERG Blockers | 0.072 | Hepatotoxicity | 0.46 |
Mutagenicity | 0.017 | Rat Oral Acute Toxicity | 0.105 |
FDAMDD | 0.428 | Skin Sensitization | 0.001 |
Carcinogenicity | 0.226 | Eye Corrosion | 0.004 |
Eye Irritation | 0.162 | Respiratory Toxicity | 0.071 |
Environmental Toxicity
Property | Value | Property | Value |
---|---|---|---|
Bioconcentration Factors | 0.472 | IGC50 | 2.457 |
LC50FM | -9.458 | LC50DM | -2.271 |
Tox21 Pathway
Property | Value | Property | Value |
---|---|---|---|
NR-AR | 0.312 | NR-AR-LBD | 0.36 |
NR-AhR | 0.039 | NR-Aromatase | 0.088 |
NR-ER | 0.529 | NR-ER-LBD | 0.918 |
NR-PPAR-gamma | 0.192 | SR-ARE | 0.449 |
SR-ATAD5 | 0.406 | SR-HSE | 0.209 |
SR-MMP | 0.015 | SR-p53 | 0.048 |
Similar covalent inhibitors
Similar covalent drugs
No similar covalent drugs found for this compound.